Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2021

Commission File Number: 001-40414

 

 

Skylight Health Group Inc.

(Exact name of Registrant as specified in its charter)

 

 

5520 Explorer Drive, Suite 402

Mississauga, Ontario L4W 5L1

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☐                Form 40-F  ☒

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

 

 

 

---

INCORPORATION BY REFERENCE

Exhibits 99.1 and 99.3 of this Form 6-K are incorporated by reference as a additional exhibits to the registrant’s Registration Statement on Form F-10 (File No. 333-255444).

DOCUMENTS INCLUDED AS PART OF THIS REPORT

 

Exhibit
99.1		Material Change Report dated December 7, 2021
99.2		Underwriting Agreement dated December 1, 2021
99.3		Consent of Ellenoff Grossman & Schole LLP
99.4		Consent of Gardiner Roberts LLP
99.5		Consent of Grant Thornton LLP

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

						Skylight Health Group Inc.
						(Registrant)
Date: December 7, 2021						/s/ Pradyum Sekar
						Pradyum Sekar
						Chief Executive Officer and Director